3.805
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
Compass Therapeutics to present data on cancer bispecific antibody - Investing.com
Compass Therapeutics Announces Preclinical Success of CTX-10726 in Targeting Tumor Angiogenesis and Immune Suppression - Quiver Quantitative
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting - Stock Titan
Can Compass Therapeutics Inc. recover in the next quarterJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Will Compass Therapeutics Inc. stock outperform growth indexesJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
How to interpret RSI for Compass Therapeutics Inc. stockGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
Compass Therapeutics to Participate in Upcoming November Investor Events - Yahoo Finance
How Compass Therapeutics Inc. stock performs in weak economyJuly 2025 Fed Impact & Community Shared Stock Ideas - newser.com
Institutional investors in Compass Therapeutics, Inc. (NASDAQ:CMPX) lost 9.0% last week but have reaped the benefits of longer-term growth - Yahoo Finance
Why Compass Therapeutics Inc. stock is seen as undervaluedQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
How Compass Therapeutics Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Is Compass Therapeutics Inc. stock recession proof2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Will Compass Therapeutics Inc. stock split attract more investorsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
How Compass Therapeutics Inc. stock trades before earningsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) - Insider Monkey
14 Stocks Under $5 with Highest Upside Potential - Insider Monkey
How to track smart money flows in Compass Therapeutics Inc.Quarterly Investment Review & Weekly High Potential Alerts - newser.com
Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment - TipRanks
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):